ACHILLION PHARMACEUTICALS IN's ticker is ACHN and the CUSIP is 00448Q201. A total of 94 filers reported holding ACHILLION PHARMACEUTICALS IN in Q4 2013. The put-call ratio across all filers is 0.09 and the average weighting 0.1%.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q4 2019 | $275,000 | -57.3% | 45,651 | -74.5% | 0.00% | – |
| Q3 2019 | $644,000 | +2.9% | 179,274 | -23.5% | 0.00% | – |
| Q2 2019 | $626,000 | -57.6% | 234,449 | -53.1% | 0.00% | -100.0% |
| Q1 2019 | $1,477,000 | +249.2% | 499,420 | +87.1% | 0.00% | – |
| Q4 2018 | $423,000 | -92.1% | 266,931 | -81.7% | 0.00% | -100.0% |
| Q3 2018 | $5,362,000 | -52.4% | 1,457,770 | -63.4% | 0.00% | -33.3% |
| Q2 2018 | $11,259,000 | +61.0% | 3,978,914 | +111.1% | 0.00% | 0.0% |
| Q1 2018 | $6,992,000 | -5.4% | 1,885,235 | -26.5% | 0.00% | -40.0% |
| Q4 2017 | $7,388,000 | -1.2% | 2,566,018 | +54.1% | 0.01% | 0.0% |
| Q3 2017 | $7,474,000 | +24.7% | 1,665,159 | +27.5% | 0.01% | +25.0% |
| Q2 2017 | $5,992,000 | -1.9% | 1,305,900 | -10.0% | 0.00% | -20.0% |
| Q1 2017 | $6,109,000 | -17.4% | 1,451,693 | -19.0% | 0.01% | -16.7% |
| Q4 2016 | $7,396,000 | -48.3% | 1,791,322 | +1.5% | 0.01% | -40.0% |
| Q3 2016 | $14,297,000 | +23.2% | 1,765,275 | +18.7% | 0.01% | +25.0% |
| Q2 2016 | $11,600,000 | +10.0% | 1,487,623 | +8.8% | 0.01% | 0.0% |
| Q1 2016 | $10,550,000 | -31.0% | 1,366,854 | -3.6% | 0.01% | -27.3% |
| Q4 2015 | $15,288,000 | +212.8% | 1,417,274 | +100.3% | 0.01% | +175.0% |
| Q3 2015 | $4,887,000 | -10.1% | 707,551 | +15.2% | 0.00% | +33.3% |
| Q2 2015 | $5,438,000 | -39.0% | 614,168 | -32.1% | 0.00% | -50.0% |
| Q1 2015 | $8,910,000 | +70.0% | 903,974 | +111.1% | 0.01% | +100.0% |
| Q4 2014 | $5,242,000 | +51.2% | 428,169 | +23.1% | 0.00% | +50.0% |
| Q3 2014 | $3,467,000 | +99.7% | 347,685 | +51.5% | 0.00% | +100.0% |
| Q2 2014 | $1,736,000 | +1.7% | 229,568 | -55.8% | 0.00% | 0.0% |
| Q1 2014 | $1,707,000 | +62.7% | 519,152 | +62.0% | 0.00% | 0.0% |
| Q4 2013 | $1,049,000 | +44.7% | 320,515 | +31.1% | 0.00% | 0.0% |
| Q3 2013 | $725,000 | – | 244,428 | – | 0.00% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| RA Capital Management | 12,033,220 | $92,896,000 | 11.87% |
| RTW INVESTMENTS, LP | 2,558,859 | $19,754,000 | 7.17% |
| TURNER INVESTMENTS LLC | 859,560 | $6,636,000 | 1.80% |
| DAFNA Capital Management LLC | 236,500 | $1,826,000 | 1.58% |
| Ghost Tree Capital, LLC | 250,000 | $1,930,000 | 1.09% |
| Orbimed Advisors | 11,519,700 | $88,932,000 | 0.94% |
| Rock Springs Capital Management LP | 1,220,000 | $9,418,000 | 0.79% |
| Opus Point Partners Management, LLC | 99,000 | $764,000 | 0.59% |
| Bellevue Group AG | 420,000 | $3,242,000 | 0.59% |
| Cormorant Asset Management, LP | 500,000 | $3,860,000 | 0.58% |